programmed cell death protein 1
Quick Summary
Programmed cell death protein 1 (PD-1) is a protein found on the surface of T cells, which are a type of immune cell. PD-1 acts as a crucial regulator of immune responses. In essence, it functions as a "brake" on the immune system, preventing T cells from attacking the body's own healthy cells and causing autoimmune diseases.1
However, cancer cells can exploit this mechanism. They can express molecules that bind to PD-1, effectively shutting down the T cells' ability to recognize and eliminate the cancer. This is why PD-1 is a target for cancer immunotherapy. By developing antibodies that block PD-1, scientists have created treatments that release the "brake" on T cells, allowing them to attack and destroy cancer cells more effectively. This approach has shown significant promise in treating various types of cancer.234
Ask Britannica AI about this topic
Britannica doesn't have a full article on this topic, so we've curated a list of our relevant coverage.
immune systemImmunity against cancer…immune regulatory protein known as programmed cell death protein 1 (PD-1), which occurs on the surface of T cells, led to the development of highly effective anti-PD-1 cancer immunotherapies.
Read More…immune regulatory protein known as programmed cell death protein 1 (PD-1), which occurs on the surface of T cells, led to the development of highly effective anti-PD-1 cancer immunotherapies.
Read More
cancerImmunotherapy…been achieved with inhibitors of programmed cell death 1 (PD-1), a protein expressed on the surface of T cells that negatively regulates T cell activity and that is overexpressed in many cancers. Anti-PD-1 therapies, such as nivolumab and pembrolizumab, have proven beneficial in patients with melanoma and certain other cancer…
Read More…been achieved with inhibitors of programmed cell death 1 (PD-1), a protein expressed on the surface of T cells that negatively regulates T cell activity and that is overexpressed in many cancers. Anti-PD-1 therapies, such as nivolumab and pembrolizumab, have proven beneficial in patients with melanoma and certain other cancer…
Read More